Comparative evaluation of the biological properties of reducible and acid-sensitive folate prodrugs of a highly potent doxorubicin derivative
48
13
2054
2065
Klinik für Tumorbiologie, Freiberg am Neckar, Baden-Wurttemberg, Germany; Department of Chemistry, Al-Aqsa University, Gaza Strip, Palestine; Drug Discovery, Mivenion GmbH, Berlin, Germany; Pharmacology and Toxicology Department, Faculty of Pharmacy, Ain Shams University, Cairo, Cairo, Egypt; Max Delbruck Center for Molecular Medicine, Berlin, Germany
Abu Ajaj, Khalid, Klinik für Tumorbiologie, Freiberg am Neckar, Baden-Wurttemberg, Germany; El-Abadla, Naser Said, Department of Chemistry, Al-Aqsa University, Gaza Strip, Palestine; Welker, Pia, Drug Discovery, Mivenion GmbH, Berlin, Germany; Azab, Samar Saad Eldeen, Pharmacology and Toxicology Department, Faculty of Pharmacy, Ain Shams University, Cairo, Cairo, Egypt; Zeisig, Reiner, Max Delbruck Center for Molecular Medicine, Berlin, Germany; Fichtner, Iduna, Max Delbruck Center for Molecular Medicine, Berlin, Germany; Kratz, Felix, Klinik für Tumorbiologie, Freiberg am Neckar, Baden-Wurttemberg, Germany
F. Kratz; Tumor Biology Center, 79106 Freiburg, Breisacher Strasse 117, Germany; email: kratz@tumorbio.uni-freiburg.de
